About This Report

Robotic-Assisted Surgical Devices, Market Size Valuation, Share Analysis, and Growth Rate by Segments such as Type and Distribution Channel, Company Share, Competitive Landscape, and Trends Analysis

Robotic-Assisted Surgical Devices are leading-edge surgical instruments that help surgeons execute difficult surgeries with more accuracy. These gadgets are made up of robotic arms that are loaded with small instruments and a high-definition camera. Surgeons operate the robotic arms from a control panel, which displays a 3D picture of the surgery area. The surgeon's moves are translated into precise gestures by the robot, resulting in a minimally invasive procedure and increased flexibility. Patients who undergo robotic-assisted surgery frequently have shorter hospital stays, less blood loss, and faster recovery times. Without the robot's aid, the surgeon maintains complete control of the process altogether. This technology is evolving, broadening the range of surgeries that may benefit from its use.
In 2022, the Robotic-Assisted Surgical Devices market was valued at US$ YY million, and it is anticipated to be around US$ YY million by 2030. Over the forecast period, the market is expected to grow at a CAGR of YY%.

Advancements in robotic surgical technology and the increasing prevalence of chronic diseases are the drivers while high initial costs and maintenance expenses are a restraint

Robotic surgical advances in technology have been a primary driver of the use of robotic-assisted surgical equipment. These developments have enhanced robotic systems' precision, visualization, and overall capabilities, making them essential tools for difficult surgeries. For example, the da Vinci Surgical System by Intuitive Surgical has become one of the finest and most popular robotic surgical systems on the current market. Over the years, Intuitive Surgical continually enhances the system with advances such as modern imaging technology, greater surgeon ergonomics, and enhanced instrumentation, making it possible for more accurate and minimally invasive surgeries.
Furthermore, the growing number of chronic diseases has increased the need for new surgical techniques that are capable of handling complex medical situations. Robotic-assisted surgical devices have advantages such as lower trauma, quicker healing times, and better results, which makes them an appealing choice for chronic disease management. For instance, the World Health Organisation (WHO) reports that cardiovascular illnesses are the main cause of death worldwide, resulting in around 17.9 million deaths per year. The rising prevalence of chronic diseases including such has driven up demand for advanced surgical technology like robotic-assisted surgical equipment.
However, the high beginning costs involved in procuring and installing these systems are one of the key barriers to the broad adoption of robotic-assisted surgical instruments. Furthermore, continuing maintenance and software updates might increase overall costs. For instance, according to a study published in JAMA Surgery, the average acquisition cost of a robotic surgical system is roughly USD 2 million, with yearly maintenance costs of around USD 140,000. These costs may provide financial difficulties for some healthcare organizations, particularly smaller or limited resources.

General surgery is expected to account for a significant market share in the application segment

The global Robotic-Assisted Surgical Devices market is mainly classified based on product type, application, and end-user. On the basis of product type, the market is classified into instruments and accessories, robotic surgical systems, and services. By application, the market is categorized into general surgery, urology, Gynecology, Orthopedics, neurosurgery, cardiothoracic surgery, and other applications. On the basis of end-user, the market is segmented into hospitals, ambulatory surgical centers, and specialty clinics.
On the basis of application, general surgery is expected to hold the largest market share globally. General surgery involves a broad spectrum of surgical procedures and conditions, making it one of the principal applications for robotic-assisted surgical devices. in the capacity to execute advanced and precise treatments with little the spread of disease, these devices are becoming more prevalent in general surgery. In general surgery, the utilization of robotic-assisted surgical instruments results in fewer bleeds, less time in the hospital, quicker recovery times, and better patient outcomes. Furthermore, developments in technology, physician training, and the increased acceptability of minimally invasive procedures have fuelled the adoption of robotic systems in general surgery. For instance, the adoption of robotic-assisted surgery in general surgery is increasing dramatically, according to a study published in the Journal of Robotic Surgery. As per the survey, the number of general surgery procedures conducted utilizing robotic-assisted equipment climbed by more than 30% between 2012 and 2018.
Robotic surgical technology advancements have made it easier for doctors to undertake general surgery operations with robotic-assisted instruments. Furthermore, substantial training programs offered by device manufacturers and medical institutes have increased surgeons' ability to use these devices. According to one study published in JAMA Surgery, a rising number of doctors are completing robotic surgical training, which is contributing to an increase in the use of robotic-assisted surgery in general surgery. As per the survey, almost 6,700 surgeons completed robotic training in 2018, a significant rise from previous years.

Interesting Facts of Robotic-Assisted Surgical Devices Market

• By end-user, the Hospital segment is expected to hold the major market share worldwide due to their enormous surgical capabilities and patient numbers, hospitals are the principal end-users of robotic-assisted surgical instruments. Robotic technologies have been incorporated into hospital operating rooms to carry out a variety of surgical procedures across multiple disciplines.
• Based on the product type, the Robotic Surgical Systems segment grabbed the top position globally. Robotic surgical platforms, frequently referred to as robotic surgical systems, are the foundation of robotic-assisted surgery. These systems are made up of robotic arms with several joints and specialized surgical instruments that the surgeon controls from a control surface.
• Asia Pacific region is seeing strong expansion in the Robotic-Assisted Surgical Devices market due to the rising healthcare expenditure, increased medical tourism, and rising demand for innovative healthcare technology, Countries such as India, China, Japan, and South Korea are pioneers in the use of robotics surgery technology, while other emerging countries offer major potential opportunities.
• Europe has a prominent presence in the sector of Robotic-Assisted Surgical Devices, owing to its superior healthcare infrastructure and broad acceptance of breakthrough medical technologies. This area has widely recognized laws and regulations and a trained workforce, both of which contribute to the effective implementation of robotic-assisted surgery across multiple medical specialties.
• South Africa's Robotic-Assisted Surgical Devices market is gradually expanding, driven by developments in healthcare infrastructure and growing recognition of the positive effects of robotic-assisted surgeries. While adoption is lower in this region than in others, the country's expanding investments in healthcare technology are projected to spur additional growth in the business.

North America will account for the largest share of the Robotic-Assisted Surgical Devices industry

North America accounted for the lion's share of the Robotic-Assisted Surgical Devices market. The region has been at the leading edge of robotic-assisted surgical technology adoption and integration into healthcare systems. North America is home to some of the world's major manufacturers of robotic-assisted surgical devices, and the region has seen considerable developments in robotic technology. The widespread use of these devices in numerous medical disciplines has been spurred by the development of cutting-edge robotic systems and constant improvement.
In comparison to other regions, the United States has a substantial amount of healthcare spending. This monetary investment in healthcare infrastructure and technologies, such as robotic-assisted surgical gadgets, has aided the market's expansion. The United States, as the most populous market for healthcare in North America, has a higher annual expenditure on healthcare than other countries. According to the Centres for Medicare and Medicaid Services (CMS), medical expenses in the United States hit $3.8 trillion in 2019. This significant expenditure in health care systems and technologies, such as robotic-assisted surgical instruments, has led to the region's market dominance.
In the United States, the Centres for Medicare and Medicaid Services (CMS) introduced particular Current Procedural Terminology (CPT) codes for robotic-assisted surgical operations, allowing funding for these types of surgeries simpler for medical professionals. Such favourable reimbursement rules have motivated healthcare organizations and hospitals to use robotic-assisted surgical systems, helping North America maintain its market leadership.

Global Robotic-Assisted Surgical Devices Market Key Players:

Some of the major competitors in the global Robotic-Assisted Surgical Devices market include Intuitive Surgical, Inc., Corindus Vascular Robotics, Inc. (acquired by Siemens Healthineers), Medrobotics Corporation, CMR Surgical Ltd, Microbot Medical Inc., Auris Health, Inc. (acquired by Johnson & Johnson), Verb Surgical Inc., TransEnterix, Inc., Smith & Nephew plc, Zimmer Biomet Holdings, Inc., Medtronic plc, and Stryker Corporation.
Robotic-Assisted Surgical Devices is extremely competitive with aggressive market strategies of global and regional companies looking to strengthen their market position through new product launches and facility expansions. The following are some recent market developments:

• Intuitive Surgical extended its global expansion efforts in 2021 by gaining regulatory licenses for its da Vinci Surgical System in new markets, allowing the business to reach a bigger client base and increase its market presence.
• Smith & Nephew expanded its surgical robot services through strategic acquisitions. Intuitive Surgical's robotic-assisted orthopedic surgery business was bought by the company in 2020, increasing its portfolio to include advanced robotic technologies for orthopedic operations.
• Johnson & Johnson closed their purchase of Auris Health, an organization noted for creating robotic technologies for diagnostic and therapeutic operations, in February 2019. This strategic decision aims to strengthen Johnson & Johnson's position in the market for robotic-assisted surgical instruments.
• Medtronic continued its focus on innovation, launching the Hugo™ RAS System in 2021. The Company has introduced the Hugo™ RAS System, their next-generation robotic-assisted surgical platform, which is designed to aid in difficult surgeries with increased versatility and control.
• TransEnterix, a medical device startup, has made significant progress in commercializing its Senhance® Surgical System. The company got regulatory approval for additional surgical indications and expanded its international footprint.

Frequently asked questions about the global Robotic-Assisted Surgical Devices market

Q: What is the current size of the global Robotic-Assisted Surgical Devices market?
Ans: The Robotic-Assisted Surgical Devices market was valued at YY million US$ in 2020 and is projected to reach YY million US$ by 2027, at a CAGR of YY% during the forecast period.

Q: What are the major opportunities in the Robotic-Assisted Surgical Devices industry?
Ans: Expanding applicability to new fields of medicine, developments in robotic technology for enhanced surgical results, and increasing acceptance in emerging regions with expanded healthcare infrastructure are the primary possibilities in the Robotic-Assisted Surgical Devices sector.

Q: What is the major growth driving factor for the Robotic-Assisted Surgical Devices industry?
Ans: The rising need for safer surgical procedures is a primary growth driver for the Robotic-Assisted Surgical Devices business.

Q: Which region is expected to have the largest share of the Robotic-Assisted Surgical Devices market?
Ans: North American region is expected to have the largest share of the Robotic-Assisted Surgical Devices market

Q: Which end-user segment will dominate the Robotic-Assisted Surgical Devices market?
Ans: By end-user, the Hospital segment is expected to hold the major market share worldwide due to their enormous surgical capabilities and patient numbers, hospitals are the principal end-users of robotic-assisted surgical instruments.